136 results match your criteria: "Translational Transplant Research Center[Affiliation]"

Borderline rejection: To treat or not to treat?

Transpl Immunol

June 2024

Department of Medicine and Surgery, University of Parma, Parma, Italy; Nephrology Unit, University Hospital of Parma, Parma, Italy. Electronic address:

Article Synopsis
  • The study examines the necessity of treatment with intravenous steroids versus clinical follow-up for kidney transplant recipients diagnosed with "borderline" acute T-cell mediated rejection (TCMR).
  • Researchers followed 59 patients over 12 months, comparing the groups receiving treatment (TRT) and those with simple clinical follow-up (F-UP), measuring trends in renal function through estimated glomerular filtration rate (eGFR).
  • Results showed that while the TRT group initially had lower kidney function, they reached comparable eGFR levels to the F-UP group after 12 months, indicating that treatment may be beneficial in cases with indication biopsies.
View Article and Find Full Text PDF

Immune cell metabolism plays a pivotal role in shaping and modulating immune responses. The metabolic state of immune cells influences their development, activation, differentiation, and overall function, impacting both innate and adaptive immunity. While glycolysis is crucial for activation and effector function of CD8 T cells, regulatory T cells mainly use oxidative phosphorylation and fatty acid oxidation, highlighting how different metabolic programs shape immune cells.

View Article and Find Full Text PDF

The spatially resolved transcriptome signatures of glomeruli in chronic kidney disease.

JCI Insight

March 2024

Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, USA.

Here, we used digital spatial profiling (DSP) to describe the glomerular transcriptomic signatures that may characterize the complex molecular mechanisms underlying progressive kidney disease in Alport syndrome, focal segmental glomerulosclerosis, and membranous nephropathy. Our results revealed significant transcriptional heterogeneity among diseased glomeruli, and this analysis showed that histologically similar glomeruli manifested different transcriptional profiles. Using glomerular pathology scores to establish an axis of progression, we identified molecular pathways with progressively decreased expression in response to increasing pathology scores, including signal recognition particle-dependent cotranslational protein targeting to membrane and selenocysteine synthesis pathways.

View Article and Find Full Text PDF

Recurrent C3 glomerulopathy after kidney transplantation.

Transplant Rev (Orlando)

April 2024

Precision Immunology Institute, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America. Electronic address:

The complement system is part of innate immunity and is pivotal in protecting the body against pathogens and maintaining host homeostasis. Activation of the complement system is triggered through multiple pathways, including antibody deposition, a mannan-binding lectin, or activated complement deposition. C3 glomerulopathy (C3G) is a rare glomerular disease driven by complement dysregulation with high post-transplantation recurrence rates.

View Article and Find Full Text PDF

Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study.

Am J Transplant

June 2024

Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Medicine, Nephrology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address:

Membranous nephropathy (MN) is a leading cause of kidney failure worldwide and frequently recurs after transplant. Available data originated from small retrospective cohort studies or registry analyses; therefore, uncertainties remain on risk factors for MN recurrence and response to therapy. Within the Post-Transplant Glomerular Disease Consortium, we conducted a retrospective multicenter cohort study examining the MN recurrence rate, risk factors, and response to treatment.

View Article and Find Full Text PDF
Article Synopsis
  • Medical researchers are increasingly concerned about the impact of microplastics on human health, particularly in organs and tissues like the kidneys. !* -
  • A study utilized microRaman spectroscopy to analyze kidney and urine samples from healthy individuals, identifying 26 microplastic particles in both, ranging in size from 1 to 29 μm. !* -
  • The polymers found most often were polyethylene and polystyrene, while pigments included hematite and Cu-phthalocyanine, marking the first documented evidence of microplastics in human kidney tissues and urine. !*
View Article and Find Full Text PDF

C3aR-initiated signaling is a critical mechanism of podocyte injury in membranous nephropathy.

JCI Insight

January 2024

GOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics in Urology, Saban Research Institute, Division of Urology, Children's Hospital Los Angeles (CHLA), Los Angeles, California, USA.

Article Synopsis
  • Antipodocyte autoantibodies cause primary membranous nephropathy (MN), a leading cause of nephrotic syndrome, and this was modeled using a glomerulus-on-a-chip system with anti-PLA2R antibodies.
  • The study found that MN serum exposure led to harmful IgG deposition and complement activation on podocytes, decreasing their ability to filter albumin, but blocking C3aR reduced this oxidative stress and leakage.
  • C3aR antagonism not only mitigated damage in vitro but also prevented proteinuria in a mouse model, highlighting C3a/C3aR signaling as a potential new treatment target for MN.
View Article and Find Full Text PDF

T-cell receptor sequencing reveals selected donor-reactive CD8 T cell clones resist antithymocyte globulin depletion after kidney transplantation.

Am J Transplant

May 2024

Translational Transplant Research Center, Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Immunology Institute Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address:

High frequencies of donor-reactive memory T cells in the periphery of transplant candidates prior to transplantation are linked to the development of posttransplant acute rejection episodes and reduced allograft function. Rabbit antithymocyte globulin (rATG) effectively depletes naïve CD4 and CD8 T cells for >6 months posttransplant, but rATG's effects on human donor-reactive T cells have not been carefully determined. To address this, we performed T cell receptor β-chain sequencing on peripheral blood mononuclear cells aliquots collected pretransplant and serially posttransplant in 7 kidney transplant recipients who received rATG as induction therapy.

View Article and Find Full Text PDF
Article Synopsis
  • - Focal segmental glomerulosclerosis (FSGS) is a major cause of kidney failure, often recurring after transplants and increasing the risk of graft failure.
  • - Standard treatments like plasma exchange and rituximab have variable effectiveness, prompting the search for new solutions.
  • - This report presents five cases of early FSGS recurrence post-kidney transplant that were resistant to standard therapies but improved significantly when treated with a combination of rituximab and daratumumab, suggesting it may be a promising approach for clinical trials.
View Article and Find Full Text PDF

Foxp3 acetylation is essential to regulatory T (Treg) cell stability and function, but pharmacologically increasing it remains an unmet challenge. Here, we report that small-molecule compounds that inhibit TIP60, an acetyltransferase known to acetylate Foxp3, unexpectedly increase Foxp3 acetylation and Treg induction. Utilizing a dual experimental/computational approach combined with a newly developed FRET-based methodology compatible with flow cytometry to measure Foxp3 acetylation, we unraveled the mechanism of action of these small-molecule compounds in murine and human Treg induction cell cultures.

View Article and Find Full Text PDF

Exchangeable Self-Assembled Lanthanide Antennas for PLIM Microscopy.

Angew Chem Int Ed Engl

February 2024

Nanoscopy-UGR Laboratory. Departamento de Fisicoquímica, Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente, Facultad de Farmacia, Universidad de Granada, Campus Cartuja, 18071, Granada, Spain.

Lanthanides have unique photoluminescence (PL) emission properties, including very long PL lifetimes. This makes them ideal for biological imaging applications, especially using PL lifetime imaging microscopy (PLIM). PLIM is an inherently multidimensional technique with exceptional advantages for quantitative biological imaging.

View Article and Find Full Text PDF

Human Natural Killer (NK) cells are heterogeneous lymphocytes regulated by variegated arrays of germline-encoded activating and inhibitory receptors. They acquire the ability to detect polymorphic self-antigen via NKG2A/HLA-E or KIR/HLA-I ligand interactions through an education process. Correlations among HLA/KIR genes, kidney transplantation pathology and outcomes suggest that NK cells participate in allograft injury, but mechanisms linking NK HLA/KIR education to antibody-independent pathological functions remain unclear.

View Article and Find Full Text PDF

Role of complement in humoral immunity.

Curr Opin Organ Transplant

October 2023

Translational Transplant Research Center and Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Purpose Of Review: Antibody-mediated rejection (AMR) after solid organ transplantation remains an unsolved problem and leads to poor early and late patient outcomes. The complement system is a well recognized pathogenic mediator of AMR. Herein, we review the known molecular mechanisms of disease and results from ongoing clinical testing of complement inhibitors after solid organ transplant.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effects of naturally occurring erythropoietin (EPO) on immune function in mice, specifically its role in regulating lupus.
  • Researchers created a mouse model to reduce EPO production and assessed immune responses over time, including antibody levels and disease severity.
  • Findings reveal that lower EPO levels led to increased autoantibodies and disease severity in lupus, suggesting that EPO plays a protective role in maintaining immune balance.
View Article and Find Full Text PDF

TACI and endogenous APRIL in B cell maturation.

Clin Immunol

August 2023

Division of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA; Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.

While many of the genes and molecular pathways in the germinal center B cell response which initiate protective antibody production are known, the contributions of individual molecular players in terminal B cell differentiation remain unclear. We have previously investigated how mutations in TACI gene, noted in about 10% of patients with common variable immunodeficiency, impair B cell differentiation and often, lead to lymphoid hyperplasia and autoimmunity. Unlike mouse B cells, human B cells express TACI-L (Long) and TACI-S (Short) isoforms, but only TACI-S promotes terminal B cell differentiation into plasma cells.

View Article and Find Full Text PDF

Immune abnormalities in IgA nephropathy.

Clin Kidney J

July 2023

Translational Transplant Research Center and Department of Medicine, Icahn School of Medicine at Mount Sinai, NY, USA.

Article Synopsis
  • IgA nephropathy (IgAN) is the most common type of kidney inflammation globally, marked by the accumulation of IgA in the kidney's mesangial cells, leading to symptoms like blood in urine and protein loss.
  • About 20%-40% of those affected may end up with severe kidney damage within two decades of the disease starting.
  • The development of IgAN involves a series of processes that begin with abnormal IgA production and lead to immune responses that cause inflammation and kidney injury, with ongoing research exploring the underlying immune mechanisms and genetic influences.
View Article and Find Full Text PDF

Background: Hepatitis B virus (HBV) vaccination is indicated for all end stage kidney disease patients, including all solid organ transplant candidates. Maintenance of adequate immunity is especially important for immunosuppressed solid organ recipients who are at increased risk for donor or community acquired HBV. The impact of age and immunosuppression on long-term maintenance of HBV immunity postvaccination has not been fully investigated.

View Article and Find Full Text PDF

Glomerular crescents and the rapid sunset of kidney function.

J Nephrol

November 2023

Department of Medicine, Translational Transplant Research Center (TTRC), Icahn School of Medicine at Mount Sinai, 1 Levy Place, New York, NY, 10029, USA.

View Article and Find Full Text PDF

The current tools for diagnosing and monitoring native kidney diseases as well as allograft rejection in transplant patients are suboptimal. Creatinine and proteinuria are non-specific and poorly sensitive markers of injury. Tissue biopsies are invasive and carry potential complications.

View Article and Find Full Text PDF

Identification and Characterization of the Wilms Tumor Cancer Stem Cell.

Adv Sci (Weinh)

July 2023

GOFARR Laboratory, Children's Hospital Los Angeles, Division of Urology, Saban Research Institute, Los Angeles, CA, 90027, USA.

A nephrogenic progenitor cell (NP) with cancer stem cell characteristics driving Wilms tumor (WT) using spatial transcriptomics, bulk and single cell RNA sequencing, and complementary in vitro and transplantation experiments is identified and characterized. NP from WT samples with NP from the developing human kidney is compared. Cells expressing SIX2 and CITED1 fulfill cancer stem cell criteria by reliably recapitulating WT in transplantation studies.

View Article and Find Full Text PDF

Background: Kidney transplant recipients are currently treated with nonspecific immunosuppressants that cause severe systemic side effects. Current immunosuppressants were developed based on their effect on T-cell activation rather than the underlying mechanisms driving alloimmune responses. Thus, understanding the role of the intragraft microenvironment will help us identify more directed therapies with lower side effects.

View Article and Find Full Text PDF

Type I interferons augment regulatory T cell polarization in concert with ancillary cytokine signals.

Front Transplant

April 2023

Transplantation Research Center, Division of Nephrology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.

In the transplant community, research efforts exploring endogenous alternatives to inducing tolerogenic allo-specific immune responses are much needed. In this regard, CD4 FoxP3 regulatory T cells (T) are appealing candidates due to their intrinsic natural immunosuppressive qualities. To date, various homeostatic factors that dictate T survival and fitness have been elucidated, particularly the non-redundant roles of antigenic CD3/T-cell-receptor, co-stimulatory CD28, and cytokine interleukin (IL-)2 dependent signaling.

View Article and Find Full Text PDF